Apo A-I Deficiency

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Dec 21, 2021
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets
Status:
Completed
Last Changed:
Jan 1, 2016
First Changed:
May 25, 2009
Disease(s):
Hypercholesterolemia
Intervention(s):
EzetimibeRosuvastatin (standard care)
HIV Antiretroviral Drugs and Metabolism
Status:
Unknown status
Last Changed:
Mar 16, 2011
First Changed:
Sep 5, 2007
Disease(s):
HIV Infections
Intervention(s):
ritonavir, lopinavir/ritonavir, atazanavir/ritonavir, efavirenz
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection

Connect. Empower. Inspire.